Patient satisfaction isn't just about the way patients are treated by physicians and staff. The equipment and products used in healthcare facilities can have a significant impact on patient opinion, according to an industry report.
Abbott waffled on its commitment to purchase Alere in April because of concerns about the accuracy of Alere's statements and representations in the agreement. The North Chicago, Ill., company this month warned that it may not go through with the proposal.
Michigan's Bureau of Community and Health Systems opened the investigation after the Detroit News reported doctors had repeatedly voiced concerns about dirty surgical instruments.
The controversy surrounding Mylan's EpiPen pricing suggests drugmakers have been slow to adapt to an environment in which millions of Americans must pay thousands of dollars out of pocket before their coverage kicks in.
U.S. Sen. Joe Manchin remained mum Wednesday as a pharmaceutical company run by his daughter faced mounting criticism for hiking prices on life-saving allergy injection pens.
Guardant Health, based in Redwood City, Calif., developed a liquid biopsy blood test that has helped match cancer patients with clinical trials and treatment options without costly or invasive biopsies. CEO and co-founder Helmy Eltoukhy calls it a “game changer” for oncology.
A majority of people would participate in President Barack Obama's Precision Medicine Initiative, a volunteer federal program that collects patient data to advance research, according to a new survey.
Phelps told reporters he has used the ancient Chinese technique called cupping for years before meets.
NantHealth, the precision-medicine company started by billionaire Dr. Patrick Soon-Shiong, is in negotiations with 13 additional health insurance companies and large employers to cover its costly genome sequencing test for cancer patients.
Purple circles visible on Olympic swimmer Michael Phelps' body while he competes at the Rio Games are evidence of the superstar swimmer's belief in an ancient Chinese technique called cupping, which is touted as a way to ease sore muscles.
The decision could potentially open the floodgates for more litigation tied to the device, which thousands of women have said led to chronic pelvic pain, punctured their uteruses and caused other damage.
Pharmaceutical giant GlaxoSmithKline is forming a joint venture with a unit of Google's parent that will invest $714 million in the relatively new field of bioelectronic medicine.